Drug Regimen Review
The drug regimen review (DRR) is the required clinical screen of a home health patient's complete medication regimen for potentially clinically significant issues, such as interactions, duplications, omissions, adverse reactions, and noncompliance. It is part of the comprehensive assessment under the Conditions of Participation and is documented through OASIS items M2001, M2003, and M2005, which also feed a federal process measure.
Definition
The drug regimen review (DRR) is the required clinical screen of a home health patient's complete medication regimen for potentially clinically significant issues, such as interactions, duplications, omissions, adverse reactions, and noncompliance. It is part of the comprehensive assessment under the Conditions of Participation and is documented through OASIS items M2001, M2003, and M2005, which also feed a federal process measure.
Why it matters
Drug Regimen Review is part of the OASIS & Assessment vocabulary used across home health operations, documentation, and revenue cycle. Understanding it helps clinicians, QA leads, and administrators stay aligned on care quality and compliance.
What Should I Document? 100 OASIS Situations Home Health Nurses Face Every Day
100 real OASIS scenarios, worked end to end — clinical situation, common mistake, better approach, and key takeaway. Built around OASIS-E2 (effective April 1, 2026) to turn what you assess into accurate, defensible documentation.
Related terms
Listen While You Read
Conversations on oasis & assessment
Episodes from Inside Home Health that put Drug Regimen Review in operational context.
Ep 19Ep 19 · Jul 6, 2026
AI Won't Replace Nurses, But Nurses Using AI Will | Timi Abiola
Timi AbiolaWatch 
Ep 23Ep 23 · Aug 17, 2026
The Hidden Spreadsheet Error That's Causing the Nursing Shortage | Robert Wingo
Robert Wingo, BSN, RN, NI-BCWatch 
Ep 18Ep 18 · Jun 29, 2026
Building Healthcare AI Without Trust Is a Mistake
Jeanette YatesWatch